Trial Profile
Randomized, open-label, single centre study on ovarian stimulation in ART poor responders treated with recombinant FSH in association with recombinant LH.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Aug 2013
Price :
$35
*
At a glance
- Drugs Follitropin alfa/lutropin alfa (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Therapeutic Use
- 10 Aug 2013 Planned number of patients changed from 12 to 120 as reported by European Clinical Trials Database.
- 10 Aug 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 12 Jul 2012 New trial record